F2RL3 and colorectal carcinoma: Figure 7 shows parallel rightward shifts in the PAR4 CRC in response to increasing concentrations of compound, indicative of a competitive mechanism of action for both YD-3 (Figure 7A) and 1 (Figure 7B).